MATURITAS, cilt.49, ss.221-227, 2004 (SCI İndekslerine Giren Dergi)
Objective: To investigate the effects of hormone therapy (HT) administered to postmenopausal women on pulmonary function tests (PFT). Methods: Eighty-two postmenopausal women who were having natural or surgically initiated menopause and had no risk factor that could affect the respiratory system were included into this prospective, randomized study. Twenty-five women who refused to use HT were assessed as the control group (Group I). Nineteen women who accepted using HT and who were having surgically initiated menopause were given continuous estrogen (Group II), 23 were given continuous estrogen and progesterone in combination (Group III) and 15 were given cyclic estrogen and progesterone combination (Group IV).